Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis
- 20 July 2016
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 9 (5), 359-368
- https://doi.org/10.1177/1756285616659411
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 37 references indexed in Scilit:
- Graphical Tools for Network Meta-Analysis in STATAPLOS ONE, 2013
- Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare SettingPharmacoEconomics, 2013
- Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic ReviewsInternational Journal of Epidemiology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias)Journal of Clinical Epidemiology, 2011
- Newly Identified Events in the RE-LY TrialThe New England Journal of Medicine, 2010
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Can We Rely on RE-LY?The New England Journal of Medicine, 2009
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986